| Inhibition of interleukin‐1β‐stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage SM Julovi, T Yasuda, M Shimizu, T Hiramitsu, T Nakamura Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 198 | 2004 |
| Hyaluronan inhibits matrix metalloproteinase‐13 in human arthritic chondrocytes via CD44 and P38 SM Julovi, H Ito, K Nishitani, CJ Jackson, T Nakamura Journal of Orthopaedic Research 29 (2), 258-264, 2011 | 120 | 2011 |
| Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1β-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts … T Hiramitsu, T Yasuda, H Ito, M Shimizu, SM Julovi, T Kakinuma, ... Rheumatology 45 (7), 824-832, 2006 | 85 | 2006 |
| Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. M Shimizu, T Yasuda, T Nakagawa, E Yamashita, SM Julovi, T Hiramitsu, ... The Journal of rheumatology 30 (6), 1164-1172, 2003 | 76 | 2003 |
| Activated protein C enhances human keratinocyte barrier integrity via sequential activation of epidermal growth factor receptor and Tie2 M Xue, SO Chow, S Dervish, YKA Chan, SM Julovi, CJ Jackson Journal of biological chemistry 286 (8), 6742-6750, 2011 | 60 | 2011 |
| Protease activated receptor-2 mediates activated protein c–induced cutaneous wound healing via inhibition of p38 SM Julovi, M Xue, S Dervish, PN Sambrook, L March, CJ Jackson The American journal of pathology 179 (5), 2233-2242, 2011 | 48 | 2011 |
| Involvement of CD44 in induction of matrix metalloproteinases by a COOH‐terminal heparin‐binding fragment of fibronectin in human articular cartilage in culture T Yasuda, AR Poole, M Shimizu, T Nakagawa, SM Julovi, H Tamamura, ... Arthritis & Rheumatism 48 (5), 1271-1280, 2003 | 47 | 2003 |
| COOH-terminal heparin-binding fibronectin fragment induces nitric oxide production in rheumatoid cartilage through CD44 T Yasuda, T Kakinuma, SM Julovi, M Yoshida, T Hiramitsu, M Akiyoshi, ... Rheumatology 43 (9), 1116-1120, 2004 | 40 | 2004 |
| Cotargeting of epidermal growth factor receptor and PI3K Overcomes PI3K–Akt oncogenic dependence in pancreatic ductal adenocarcinoma MH Wong, A Xue, SM Julovi, N Pavlakis, JS Samra, TJ Hugh, AJ Gill, ... Clinical Cancer Research 20 (15), 4047-4058, 2014 | 39 | 2014 |
| CD47 promotes age-associated deterioration in angiogenesis, blood flow and glucose homeostasis K Ghimire, Y Li, T Chiba, SM Julovi, J Li, MA Ross, AC Straub, ... Cells 9 (7), 1695, 2020 | 34 | 2020 |
| Matrix metalloproteinase production by COOH-terminal heparin-binding fibronectin fragment in rheumatoid synovial cells T Yasuda, M Shimizu, T Nakagawa, SM Julovi, T Nakamura Laboratory investigation 83 (2), 153-162, 2003 | 33 | 2003 |
| Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade JL Martin, SM Julovi, MZ Lin, HC de Silva, FM Boyle, RC Baxter Breast Cancer Research 19, 1-14, 2017 | 25 | 2017 |
| Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis SM Julovi, B Sanganeria, N Minhas, K Ghimire, B Nankivell, NM Rogers Laboratory Investigation 100 (9), 1184-1196, 2020 | 24 | 2020 |
| Pharmacologic targeting of renal ischemia-reperfusion injury using a normothermic machine perfusion platform AM Hameed, DB Lu, H Burns, N Byrne, YV Chew, S Julovi, K Ghimire, ... Scientific Reports 10 (1), 6930, 2020 | 24 | 2020 |
| Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo SM Julovi, A Xue, TN Thanh LE, AJ Gill, JC Bulanadi, M Patel, ... PLoS One 11 (3), e0151475, 2016 | 21 | 2016 |
| Hyaluronan inhibits IL-1β-stimulated collagenase production via down-regulation of phosphorylated p38 in SW-1353 human chondrosarcoma cells SM Julovi, H Ito, T Hiramitsu, T Yasuda, T Nakamura Modern rheumatology 18, 263-270, 2008 | 20 | 2008 |
| Nuclear insulin-like growth factor binding protein-3 as a biomarker in triple-negative breast cancer xenograft tumors: effect of targeted therapy and comparison with chemotherapy SM Julovi, JL Martin, RC Baxter Frontiers in Endocrinology 9, 340970, 2018 | 19 | 2018 |
| Requirement of mitogen-activated protein kinase for collagenase production by the fibronectin fragment in human articular chondrocytes in culture T Yasuda, SM Julovi, T Hiramitsu, M Yoshida, T Nakamura Modern rheumatology 14 (1), 54-60, 2004 | 19 | 2004 |
| Activated protein C inhibits proliferation and tumor necrosis factor α-stimulated activation of p38, c-Jun NH2-terminal kinase (JNK) and Akt in rheumatoid synovial fibroblasts SM Julovi, K Shen, K McKelvey, N Minhas, L March, CJ Jackson Molecular Medicine 19, 324-331, 2013 | 15 | 2013 |
| The role of matrix proteins in cardiac pathology K Trinh, SM Julovi, NM Rogers International Journal of Molecular Sciences 23 (3), 1338, 2022 | 14 | 2022 |
Natasha RogersResearch Fellow, Westmead Institute for Medical ResearchAdresă de e-mail confirmată pe health.nsw.gov.au
